This paperwork
is approved on an emergency basis under the following conditions:
1) In the future, FDA will not publish guidance documents with
information collection provisions that have immediate effect
without first obtaining OMB clearance. 2) FDA will revise the
guidance document to contain the PRA mandated disclosure statement
including the collection's OMB number, expiration date and expected
burden.
Inventory as of this Action
Requested
Previously Approved
01/31/2004
01/31/2004
234
0
0
28,000
0
0
0
0
0
The Medical Device User Fee and
Modernization Act of 2002 requires manufactures of processed single
use devices to submit to FDA validation data to show that the
devices will remain safe after reprocessing in accordance with the
device labeling. New manufacturers will need to submit the data
immediately. Manufacturers with cleared devices will need to do so
within 9 months of FDA notification. Manufacturers previously
exempt will have 15 months to submit the data.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.